Curi Bio Public Market Comparables
Find the most relevant public market comparables for Curi Bio, including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Curi Bio is a biotechnology company focused on developing human-relevant platforms for drug discovery and development. The company offers advanced 3D tissue models of disease, biosystems for clinically relevant functional analyses, and AI/ML-enabled insights to inform R&D decision-making in drug safety, efficacy, and potency. Curi Bio's products and services are designed to build mature and predictive human iPSC-derived tissues, with a focus on cardiac, musculoskeletal, and neuromuscular models, supporting the preclinical drug development process.
Business Model
Curi Bio provides a preclinical discovery platform that combines human stem cells, systems, and data to accelerate the discovery of new medicines. They offer customized research services, including assay development and drug screening for its drug company partners. They also sell products for cell culture, such as the Mantarray platform for growing engineered muscle tissues and the Cytostretcher device for stretching cell experiments.
Target Customers
Large biopharmaceutical companies
Specific Focus
Human stem cell-based platforms for drug discovery
Location
Seattle, Washington
CEO
Nick Geisse
Industry
Life sciences
Sub Sector
Biotechnology
3yr Revenue Growth
967%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Curi Bio in the Life Sciences sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Curi Bio? Our platform provides detailed analysis of Curi Bio's competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Curi Bio compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Curi Bio Compset
As a leading player in the Life sciences industry within the Life Sciences sector, Curi Bio operates in the specialized Biotechnology sub-sector. Understanding how Curi Bio compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Inotiv, Inc.
Pharmaceutical industry • Life sciences
Inotiv, Inc. is a leading contract research organization (CRO) providing nonclinical and analytical drug discovery and development services, research models, and related products and services. The company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians, primarily for small molecule drug candidates, biotherapeutics, and biomedical devices. They also sell research-quality animals and diets to pharmaceutical and medical device industries, academia, and government clients.
Mersana Therapeutics, Inc.
Pharmaceuticals & Biotechnology • Life sciences
Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms.
Recursion Pharmaceuticals, Inc.
Healthcare • Life sciences
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology and chemistry to industrialize drug discovery. It uses an integrated AI-enabled full-stack platform, the Recursion Operating System (OS), to map and navigate biological and chemical relationships, accelerating the identification of potential drug treatments. The company focuses on oncology and rare diseases.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Curi Bio and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free